BEIJING–(BUSINESS WIRE)–Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, has been selected as one of the “50 Smartest Companies in China 2020” (TR50) by MIT Technology Review, a leading technology and business magazine.
Genetron Health was selected for its outstanding performance in the two areas of technological innovation and commercial operations, as well as for its development of precision oncology in China and the U.S. Previous TR50 listed corporations, such as Tesla, Tencent, Apple, IBM Johnson & Johnson, BeiGene, and Wuxi AppTec, are all industry leaders.
Since 2010, MIT Technology Review has published an annual list of the “50 Smartest Companies”, lauding companies for their respective technological innovations, business successes, and future potential. The list covers a variety of different fields, such
… Read More